Tariq Musa sold $15K of GH
Tariq Musa sold 116 shares of Guardant Health, Inc. (GH) at $130.19 on 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This is a disclosed director open-market sale under a pre-arranged Rule 10b5-1 plan; absent other new company information, it is typically treated as low-signal for fundamentals.
Market read
Traders may note the insider sale for sentiment monitoring, but the filing alone is unlikely to drive a durable repricing.
What to watch
The article doesn’t state whether other insiders are buying/selling, nor the broader context of Musa’s total holdings beyond the post-transaction figure.
Background
The article is an SEC Form 4 insider transaction disclosure for Guardant Health, reported via EDGAR.
Ticker impact
Guardant Health director Tariq Musa filed an SEC Form 4 selling 116 shares at $130.19 on 2026-06-16 under a 10b5-1 plan.
Likely minimal near-term impact; any reaction should be small and quickly mean-reverting.
The filing is a small, pre-arranged 10b5-1 open-market sale by a director, with no accompanying operational/regulatory/financial catalyst in the text.
Market effects
No sector-level read-through; this is company-specific insider liquidity disclosure only.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with periods of valuation/positioning changes; traders may still watch for follow-on insider buys or larger transactions.
Key entities
- issuerGuardant Health, Inc.
Company whose director insider transaction was disclosed on SEC Form 4.
- insiderTariq Musa
Director who sold 116 shares on 2026-06-16 under a 10b5-1 plan.
